News for Siemens Healthineers AG (SHL.DE)

The major U.S. index futures are currently pointing to a lower open on Thursday, with stocks likely to move to the downside after moving modestly higher over the two previous sessions.

European shares held steady on Thursday after suffering heavy losses in the previous session amid tariff concerns and uncertainty over U.S. rate cuts. In economic news, German producer prices climbed 0.

Siemens Healthineers AG (OTCPK:SEMHF) Q1 2025 Earnings Conference Call February 6, 2025 2:30 AM ETCompany ParticipantsMarc Koebernick - Head, IRBernd Montag...

The following slide deck was published by Siemens Healthineers AG in conjunction with their 2025 Q1 earnings call.

Revenue Growth: Nearly 6% growth in Q1.Adjusted Earnings Per Share: Growth driven by top line growth and margin expansion.Order Intake: Equipment book-to-bill

Germany stocks mixed at close of trade; DAX up 0.24%

Germany stocks lower at close of trade; DAX down 0.38%

Siemens to sell $2.6 billion stake in Siemens Energy to fund Altair acquisition

Siemens AG plans to sell a €2.5 billion ($2.6 billion) stake in Siemens Energy AG in the coming months to help fund its $10 billion acquisition of software maker Al…

**media[491359]**

Germany stocks mixed at close of trade; DAX up 0.02%

**media[480306]**

Siemens Healthineers and RadNet's Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™

Siemens Healthineers faces short-term challenges but offers long-term growth potential in imaging and radiation oncology, with 20% upside. Learn more on SEMHF stock here.

The Lung Cancer Screening Market Size sector reached a market value of USD 3.28 Billion in 2023. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 9.1% from 2023…

Shares of Siemens AG were gaining around 6 percent in the morning trading on Germany's XETRA after the conglomerate on Thursday issued positive revenue outlook for fiscal 2025, after reporting higher profit and orders in its fourth quarter.

The COVID-19 Diagnostics Market Size sector reached a market value of USD 46.76 Billion in 2021. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of -13.1% from…

Donald Trump returns to the White House, promising greater U.S. protectionism, higher tariffs and tighter immigration policies. Read on.

Increasing technology along with favorable policies drives growth in the drug screening market....